Discover SIMPONI® for children weighing at least 33 pounds (15 kg) with moderately to severely active ulcerative colitis

SIMPONI® is a prescription medicine called a tumor necrosis factor (TNF) blocker. SIMPONI® has been approved by the FDA for the treatment of several disease states and is now approved for children weighing at
least 33 pounds (15 kg) with moderately to severely active ulcerative colitis.

Pediatric Ulcerative Colitis Treatment With SIMPONI®

While individual results may vary, SIMPONI® was established in a clinical study to:

  • Help children with moderately to severely active UC control their symptoms at 6 weeks (clinical remission)
  • Help patients see improvement in symptoms at Week 6
  • Maintain remission of symptoms at 54 weeks with a single injection once every 4 weeks for those who responded to SIMPONI®

Pediatric patients knew they were on SIMPONI® for the entire study.

AT 6 WEEKS

More than 3 in 10 patients were in clinical remission at Week 6.

chart-icon

SIMPONI® (N=21/66)

The primary endpoint was clinical remission at Week 6.


AT 6 WEEKS

Over 5 out of 10 pediatric patients receiving SIMPONI® had improvement in their UC symptoms by Week 6 of treatment.

chart-icon

SIMPONI® (N=38/66)

Clinical response at Week 6 was a secondary endpoint

AT 54 WEEKS

Of the patients who were in remission at 6 weeks, over 5 out of 10 maintained remission at 1 year.

chart-icon

SIMPONI® (N=12/21)

Maintenance of clinical remission at Week 54 was a secondary endpoint

Clinical remission at 54 weeks among patients who responded to SIMPONI® at Week 6, secondary endpoint: 34% (N=13/38) of patients receiving SIMPONI®

How Does SIMPONI® Work?

Before starting a new medication, it's important to know what it is and how it works. Here's a closer look at SIMPONI®.

SIMPONI® is a TNF blocker biologic medicine

It targets and blocks a protein called TNF-alpha (tumor necrosis factor-alpha)

  • TNF-alpha is made by your immune system
  • People with diseases such as UC have too much TNF-alpha
  • Excess amounts of TNF-alpha cause your immune system to mistakenly attack healthy cells in your gastrointestinal tract
  • This can lead to inflammation, which causes the symptoms that you experience with UC

SIMPONI® specifically targets excess TNF-alpha, helping to block an underlying cause of the symptoms of UC. SIMPONI® can bind with 2 forms of TNF-alpha, and at more than 1 location.

SIMPONI® targets, binds with, and blocks excess TNF-alpha, helping to control inflammation.

SIMPONI® targets, binds with, and blocks excess TNF-alpha, helping to control inflammation

chart-icon

Blocking too much TNF-alpha can make it harder for your body to fight infections. See your doctor regularly. Tell him or her if you have side effects.

SIMPONI® is not for everyone. Only your doctor can decide if SIMPONI® is right for you.